Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.

Imajo K, Yoneda M, Kessoku T, Ogawa Y, Maeda S, Sumida Y, Hyogo H, Eguchi Y, Wada K, Nakajima A.

Int J Mol Sci. 2013 Nov 4;14(11):21833-57. doi: 10.3390/ijms141121833. Review.

2.

Genetically modified mouse models for the study of nonalcoholic fatty liver disease.

Nagarajan P, Mahesh Kumar MJ, Venkatesan R, Majundar SS, Juyal RC.

World J Gastroenterol. 2012 Mar 21;18(11):1141-53. doi: 10.3748/wjg.v18.i11.1141. Review.

3.

Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.

Takahashi Y, Soejima Y, Fukusato T.

World J Gastroenterol. 2012 May 21;18(19):2300-8. doi: 10.3748/wjg.v18.i19.2300. Review.

4.

Animal models of NASH: getting both pathology and metabolic context right.

Larter CZ, Yeh MM.

J Gastroenterol Hepatol. 2008 Nov;23(11):1635-48. doi: 10.1111/j.1440-1746.2008.05543.x. Epub 2008 Aug 21. Review.

PMID:
18752564
5.

The FLS (fatty liver Shionogi) mouse reveals local expressions of lipocalin-2, CXCL1 and CXCL9 in the liver with non-alcoholic steatohepatitis.

Semba T, Nishimura M, Nishimura S, Ohara O, Ishige T, Ohno S, Nonaka K, Sogawa K, Satoh M, Sawai S, Matsushita K, Imazeki F, Yokosuka O, Nomura F.

BMC Gastroenterol. 2013 Jul 23;13:120. doi: 10.1186/1471-230X-13-120.

6.

Animal models of nonalcoholic fatty liver disease.

Hebbard L, George J.

Nat Rev Gastroenterol Hepatol. 2011 Jan;8(1):35-44. doi: 10.1038/nrgastro.2010.191. Epub 2010 Nov 30. Review.

PMID:
21119613
7.

The adaptive endoplasmic reticulum stress response to lipotoxicity in progressive human nonalcoholic fatty liver disease.

Lake AD, Novak P, Hardwick RN, Flores-Keown B, Zhao F, Klimecki WT, Cherrington NJ.

Toxicol Sci. 2014 Jan;137(1):26-35. doi: 10.1093/toxsci/kft230. Epub 2013 Oct 4.

8.

Therapeutic role of niacin in the prevention and regression of hepatic steatosis in rat model of nonalcoholic fatty liver disease.

Ganji SH, Kukes GD, Lambrecht N, Kashyap ML, Kamanna VS.

Am J Physiol Gastrointest Liver Physiol. 2014 Feb 15;306(4):G320-7. doi: 10.1152/ajpgi.00181.2013. Epub 2013 Dec 19.

9.

Roles of adipose restriction and metabolic factors in progression of steatosis to steatohepatitis in obese, diabetic mice.

Larter CZ, Yeh MM, Van Rooyen DM, Teoh NC, Brooling J, Hou JY, Williams J, Clyne M, Nolan CJ, Farrell GC.

J Gastroenterol Hepatol. 2009 Oct;24(10):1658-68. doi: 10.1111/j.1440-1746.2009.05996.x.

PMID:
19788606
10.

Nrf2 deletion causes "benign" simple steatosis to develop into nonalcoholic steatohepatitis in mice fed a high-fat diet.

Wang C, Cui Y, Li C, Zhang Y, Xu S, Li X, Li H, Zhang X.

Lipids Health Dis. 2013 Nov 4;12:165. doi: 10.1186/1476-511X-12-165.

11.

Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.

Takahashi Y, Sugimoto K, Inui H, Fukusato T.

World J Gastroenterol. 2015 Apr 7;21(13):3777-85. doi: 10.3748/wjg.v21.i13.3777. Review.

12.

An Overview of Mouse Models of Nonalcoholic Steatohepatitis: From Past to Present.

Jacobs A, Warda AS, Verbeek J, Cassiman D, Spincemaille P.

Curr Protoc Mouse Biol. 2016 Jun 1;6(2):185-200. doi: 10.1002/cpmo.3. Review.

PMID:
27248434
13.

Genetic Factors in the Pathogenesis of Nonalcoholic Fatty Liver and Steatohepatitis.

Dongiovanni P, Romeo S, Valenti L.

Biomed Res Int. 2015;2015:460190. doi: 10.1155/2015/460190. Epub 2015 Jul 27. Review.

14.

Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition.

Charlton M, Krishnan A, Viker K, Sanderson S, Cazanave S, McConico A, Masuoko H, Gores G.

Am J Physiol Gastrointest Liver Physiol. 2011 Nov;301(5):G825-34. doi: 10.1152/ajpgi.00145.2011. Epub 2011 Aug 11. Erratum in: Am J Physiol Gastrointest Liver Physiol. 2015 Jan 15;308(2):G159.

15.

The expanding role of fish models in understanding non-alcoholic fatty liver disease.

Asaoka Y, Terai S, Sakaida I, Nishina H.

Dis Model Mech. 2013 Jul;6(4):905-14. doi: 10.1242/dmm.011981. Epub 2013 May 29. Review. Erratum in: Dis Model Mech. 2014 Mar;7(3):409.

16.

Mouse models in non-alcoholic fatty liver disease and steatohepatitis research.

Anstee QM, Goldin RD.

Int J Exp Pathol. 2006 Feb;87(1):1-16. Review.

17.

Genes of the antioxidant response undergo upregulation in a rodent model of nonalcoholic steatohepatitis.

Lickteig AJ, Fisher CD, Augustine LM, Cherrington NJ.

J Biochem Mol Toxicol. 2007;21(4):216-20.

PMID:
17721935
18.

Lipotoxicity and steatohepatitis in an overfed mouse model for non-alcoholic fatty liver disease.

Gaemers IC, Stallen JM, Kunne C, Wallner C, van Werven J, Nederveen A, Lamers WH.

Biochim Biophys Acta. 2011 Apr;1812(4):447-58. doi: 10.1016/j.bbadis.2011.01.003. Epub 2011 Jan 7.

19.

Increased diacylglycerols characterize hepatic lipid changes in progression of human nonalcoholic fatty liver disease; comparison to a murine model.

Gorden DL, Ivanova PT, Myers DS, McIntyre JO, VanSaun MN, Wright JK, Matrisian LM, Brown HA.

PLoS One. 2011;6(8):e22775. doi: 10.1371/journal.pone.0022775. Epub 2011 Aug 9.

20.

The relationship between oxidative stress and nonalcoholic fatty liver disease: Its effects on the development of nonalcoholic steatohepatitis.

Ucar F, Sezer S, Erdogan S, Akyol S, Armutcu F, Akyol O.

Redox Rep. 2013;18(4):127-33. doi: 10.1179/1351000213Y.0000000050. Epub 2013 Jun 5. Review.

PMID:
23743495

Supplemental Content

Support Center